WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Avalo Therapeutics earnings were $73.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AVTX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$13.1M, down 62.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVTX reported annual earnings of -$35.1M, with 11.4% growth.

AVTX earnings history

Current Revenue
$441.0k
Current Earnings
$73.0M
Current Profit Margin
16,556%

AVTX Return on Equity

Current Company
111%
Current Industry
-60.2%
Current Market
31.5%
AVTX's Return on Equity (111%)... subscribe to Premium to read more.
High Return on Equity Performance

AVTX undefined

Current Company
58.9%
Current Industry
-2.5%
AVTX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AVTX announces earnings.

AVTX undefined

Current Company
52.6%
Current Industry
5.8%
AVTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AVTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AVTX$70.18M$73.01MN/A-$4.01
ONCY-$22.13M-$22.50MN/A-$0.29
ATRA$7.38M-$15.64MN/A-$2.57
MAIA-$19.70M-$19.70MN/A-$0.79
CNTBN/AN/AN/AN/A
View Top Biotech Stocks

Avalo Therapeutics Earnings Reports & History FAQ

What were Avalo Therapeutics's earnings last quarter?

On AVTX's earnings call on Invalid Date, Avalo Therapeutics (NASDAQ: AVTX) reported Q1 2025 earnings per share (EPS) of -$1.25, up 99.11% year over year. Total AVTX earnings for the quarter were -$13.15 million. In the same quarter last year, Avalo Therapeutics's earnings per share (EPS) was -$141.14.

If you're new to stock investing, here's how to buy Avalo Therapeutics stock.

Is Avalo Therapeutics profitable or losing money?

As of the last Avalo Therapeutics earnings report, Avalo Therapeutics is currently profitable. Avalo Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $73.01 million, a 151.1% decrease year over year.

What was AVTX's earnings growth in the past year?

As of Avalo Therapeutics's earnings date in Invalid Date, Avalo Therapeutics's earnings has grown year over year. AVTX earnings in the past year totalled $73.01 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.